DIN 02556537 — FILRA 300 MCG
FILRA is a solution of Filgrastim marketed by JAMP PHARMA CORPORATION. The full Filgrastim monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02556537
- Brand name
- FILRA
- Active ingredient
- Filgrastim
- Strength
- 300 MCG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Granulocyte colony-stimulating factor (G-CSF) / hematopoietic agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Filgrastim products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02556545 | FILRA | 480 MCG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02441489 | GRASTOFIL | 300 MCG | SOLUTION | APOTEX INC | MARKETED |
| 02454548 | GRASTOFIL | 480 MCG | SOLUTION | APOTEX INC | MARKETED |
| 01968017 | NEUPOGEN | 300 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02420104 | NEUPOGEN | 600 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02420112 | NEUPOGEN | 600 MCG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02485575 | NIVESTYM | 300 MCG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02485591 | NIVESTYM | 300 MCG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02485583 | NIVESTYM | 480 MCG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02485656 | NIVESTYM | 480 MCG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02520990 | NYPOZI | 300 MCG | SOLUTION | TANVEX BIOPHARMA USA, INC. | MARKETED |
| 02521008 | NYPOZI | 480 MCG | SOLUTION | TANVEX BIOPHARMA USA, INC. | MARKETED |